Substituierte Benzoate-Derivate

The present invention relates to the compounds of the formula: in which R , R , R , R , R , R , R , and R are independently hydrogen, lower alkyl which is optionally substituted, lower alkoxy which is optionally substituted, hydroxy, acyloxy, or halogen; R is hydrogen, hydroxy, acyloxy, lower alkyl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TANAKA, KAZUSHIGE, NISHINOMIYA-SHI, HYOGO-KEN, JP, YOSHIDA, TADASHI, TOYONO-GUN, OSAKA-FU, JP, FUJII, YASUHIKO, KOBE-SHI, HYOGO-KEN, JP, SAKAZAKI, RYUJI, KITAKATSURAGI-GUN, NARA-KEN, JP, MATSUTANI, SHIGERU, HASHIMOTO-SHI, WAKAYAMA-KEN, JP
Format:	Patent
Sprache:	ger
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the compounds of the formula: in which R , R , R , R , R , R , R , and R are independently hydrogen, lower alkyl which is optionally substituted, lower alkoxy which is optionally substituted, hydroxy, acyloxy, or halogen; R is hydrogen, hydroxy, acyloxy, lower alkyl which is optionally substituted, lower alkoxy which is optionally substituted, or lower alkylamino which is optionally substituted; E is hydrogen, or an ester residue; m is an integer of from 1 to 4; or a pharmaceutically acceptable salt thereof. The compounds of the present invention exhibit phospholipase A2 inhibitory activity, and can be used in treating inflammatory conditions.